MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: seminole who wrote (1081)	7/21/1998 1:40:00 PM
From: David Cathcart	Read Replies (1) of 1826

Richard, MGI 114 will now get the test we have been waiting for and, as you say, things will begin to get interesting indeed. There should be continual announcements of additional phase II trials starting in the near future. Plenty of tumor types will be tested with lots of help from the NCI. We just might get that Euro partner too. Meanwhile Salagen sales are increasing and INFeD will be coming on also. We could not ask for anything more. After a quiet period this morning, it looks like some buyers are coming on now. As well they should be. Wish I had bought more options. Let's shrink some tumors! David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next